Simwon America Corp.

S-1 filed

Price $20.00 · Range $18.00 to $22.00 · 2,500,000 shares · Gross proceeds $50,000,000

DRS/A amended

DRS/A amended

DRS/A amended

DRS/A amended

DRS/A amended

DRS/A amended

Simwon America Corp. (SAC) filed a DRS/A on 2026-07-07, disclosing financial results for fiscal years 2025 and 2024. The company, a Tier 1 supplier to Tesla, Inc., reported net income of $11.3M in 2025 (down from $13.7M in 2024) with diluted EPS of $1.25 (vs. $1.52 in 2024). Key financials include $373.3M total revenue in 2025, driven primarily by automotive structural components. The filing highlights operational reliance on Tesla, revenue recognition policies under ASC 606, and temporary 2024 arrangements for packaging materials.

DRS/A amended

Simwon America Corp. reports financial performance for fiscal years 2025 and 2024, highlighting net income declines from $13.7M to $11.3M, with net income per share dropping to $1.25 from $1.52. The company remains heavily reliant on Tesla, Inc. for revenue, operating as a Tier 1 supplier of automotive structural components. A temporary 2024 arrangement involving packaging material procurement for Tesla is noted, though it was not sustained. Cash reserves decreased significantly, with ending cash balances falling to $15.5M in 2025 from $25.2M in 2024.

DRS/A amended

Simwon America Corp. (SAC) is a Tier 1 supplier of precision automotive components to Tesla, Inc., with operations in California. The filing includes audited financial statements for fiscal years 2024-2025, showing net income of $11.27M (2025) and $13.71M (2024), with EPS of $1.25 and $1.52 respectively. The company's financials highlight reliance on Tesla for nearly all revenue, with detailed disclosures on revenue recognition, accounting policies, and cash flow activities. The filing appears to be an amended submission (DRS/A) compared to the previous DRS form, incorporating updated financial data and disclosures.

DRS filed

Simwon America Corp. has filed a Draft Registration Statement (DRS) for its IPO, outlining underwriting terms including reimbursement of underwriters' expenses up to $350,000 upon closing, with $100,000 already paid as an advance. The company will issue warrants to underwriters for 5% of shares sold, exercisable at 120% of the IPO price. Lock-up agreements restrict insiders and 5% shareholders from selling shares for 180 days, while the company itself avoids issuing new securities for 90 days post-IPO. The offering includes a right of first refusal for WallachBeth and tail financing commissions. The stock is set to list on Nasdaq under [SWA], contingent on approval.